Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years (Q30537764)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years |
scientific article |
Statements
1 reference
Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years (English)
1 reference
Elise Heon
1 reference
Artur V Cideciyan
1 reference
Sanford L Boye
1 reference
William W Hauswirth
1 reference
Alexander Sumaroka
1 reference
Sharon B Schwartz
1 reference
Shalesh Kaushal
1 reference
Ramakrishna Ratnakaram
1 reference
Alejandro J Roman
1 reference
Marc C Peden
1 reference
Tomas S Aleman
1 reference
Thomas J Conlon
1 reference
Roberto Calcedo
1 reference
Ji-Jing Pang
1 reference
Kirsten E Erger
1 reference
Melani B Olivares
1 reference
Cristina L Mullins
1 reference
Malgorzata Swider
1 reference
William J Feuer
1 reference
Gerald A Fishman
1 reference
Barry J Byrne
1 reference
12 September 2011
1 reference
1 reference
9-24
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference